US Broker Ratings

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: A Potential 356.04% Upside Beckons

For investors with a keen eye on the biotechnology sector, Cullinan Therapeutics, Inc. (NASDAQ: CGEM) presents a compelling opportunity, especially considering its potential upside of 356.04%...

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring Its 5.42% Potential Upside

InnovAge Holding Corp. (NASDAQ: INNV), a healthcare company specializing in medical care facilities, presents a unique opportunity for investors looking to explore the growing sector of..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Promising 117% Upside Potential Ignites Investor Interest

Niagen Bioscience, Inc. (NAGE) is capturing the attention of investors with a compelling 117.34% potential upside, as indicated by the average analyst target price of $16.04...

Immunome, Inc. (IMNM) Investor Outlook: Strong Buy Ratings Signal Potential 109% Upside

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology company, is capturing investor attention with its promising pipeline in targeted cancer therapies. Based in Bothell, Washington, Immunome focuses..

Evolus, Inc. (EOLS) Stock Analysis: Unveiling a Potential 201% Upside with Analyst Confidence

Evolus, Inc. (NASDAQ: EOLS), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, has been capturing the attention of..

Replimune Group, Inc. (REPL): Investor Outlook on Emerging Biotech with Oncolytic Immunotherapy Potential

Replimune Group, Inc. (NASDAQ: REPL) is capturing attention in the biotech sector with its innovative approach to treating cancer through oncolytic immunotherapies. Headquartered in Woburn, Massachusetts,..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth Challenges Amidst Promising Advances in Cancer Genomics

Investors with an eye on the healthcare sector, particularly in the cutting-edge realm of cancer diagnostics and research, are likely familiar with Personalis, Inc. (NASDAQ: PSNL)...

CureVac N.V. (CVAC) Stock Analysis: Navigating a Biotech Pioneer with a Strong Return on Equity

CureVac N.V. (NASDAQ: CVAC) is a biopharmaceutical company at the forefront of mRNA-based therapeutic development. Based in Tübingen, Germany, CureVac has carved a niche in the..

Owens & Minor, Inc. (OMI)

⚠️ No article content returned.

..

Opthea Limited (OPT) Stock Analysis: Navigating the Biotech Waters with Potential Downside

Opthea Limited (NASDAQ: OPT), a crucial player in the biotechnology sector, is making waves with its innovative approach to treating serious eye conditions such as wet..

Pharvaris N.V. (PHVS) Stock Analysis: Unpacking a Potential 46% Upside Amidst Biotech Innovations

Pharvaris N.V. (PHVS), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to tackling rare diseases. Headquartered in Zug, Switzerland,..

Auna SA (AUNA) Stock Analysis: Exploring a Potential 79% Upside in the Healthcare Sector

Auna SA (AUNA), a prominent player in the healthcare sector, operates a network of hospitals and clinics across Mexico, Peru, and Colombia. With its headquarters in..

AnaptysBio, Inc. (ANAB) Stock Analysis: Biotechnology Innovator with a 65% Potential Upside

AnaptysBio, Inc. (NASDAQ: ANAB) is capturing the attention of investors with a compelling narrative of innovation in the healthcare sector, specifically in biotechnology. Based in San..

iRadimed Corporation (IRMD) Stock Analysis: A Healthcare Innovator with a 5.51% Upside Potential

iRadimed Corporation (NASDAQ: IRMD) stands out as a niche player in the healthcare sector, specializing in MRI-compatible medical devices. With its roots firmly planted in the..

Amylyx Pharmaceuticals (AMLX) Investor Outlook: Evaluating the 13.81% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a key player in the biotechnology sector, is capturing investor attention with its focus on developing innovative treatments for neurodegenerative diseases..

CorMedix Inc. (CRMD) Stock Analysis: A Promising Upside with 85.52% Growth Potential

CorMedix Inc. (NASDAQ: CRMD) is making waves in the biopharmaceutical sector, capturing investor attention with its significant growth potential. With a market capitalization of $862.55 million,..

Ginkgo Bioworks (DNA) Stock Analysis: Navigating Challenges with Biotechnology Innovations

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands as a notable player in the biotechnology sector, with its innovative approach to cell programming. Headquartered in Boston, Massachusetts,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Market Dynamics with a 38.60% Revenue Growth

Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: Unlocking a 149% Potential Upside in Rare Disease Treatment

Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a leader in the biotechnology sector, is making waves with its innovative approach to treating rare diseases. With a market capitalization..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating a 16% Potential Upside

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the U.S. healthcare sector, operates a network of general acute care hospitals. Headquartered in Franklin, Tennessee,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds